International Research-Based Pharmaceutical Manufacturers’ Association (IRPMA) General Manager, Chugai Pharma Taiwan and President of International Research-Based Pharmaceutical Manufacturers’ Association (IRPMA), discusses the continuous price cuts that plague the Taiwan market, and how IRPMA is getting involved in the discussions with the government on how to rectify this growing problem. During our interviews, general managers heading IRPMA…
Array The latest details regarding Article 46, a key piece of legislation attached to the second-generation health insurance reform, were announced this week. What are the key points to take away from this announcement? In Taiwan, the government is attempting to limit the growth of annual spending on pharmaceuticals—an expenditure that…
IRPMA (International Research-Based Pharmaceu Please describe the activities of the IRPMA to our readers, and explain the membership advantages of your association. Today the IRPMA consists of 37 multinational research-based pharmaceutical manufacturers, as well as some local R&D companies. Also, eleven individual members representing distribution and start-up biotech companies registered IRPMA for their preparation…
See our Cookie Privacy Policy Here